Unité de Fabrication des Médicaments Future Growth
Future criteria checks 4/6
Unité de Fabrication des Médicaments is forecast to grow earnings and revenue by 60.7% and 6.3% per annum respectively.
Key information
60.7%
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 19.5% |
| Revenue growth rate | 6.3% |
| Future return on equity | 19.6% |
| Analyst coverage | Low |
| Last updated | 18 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 165 | N/A | N/A | N/A | 1 |
| 12/31/2025 | 156 | 23 | 17 | 31 | 1 |
| 12/31/2024 | 146 | 19 | 13 | 26 | 1 |
| 6/30/2024 | 141 | 6 | 19 | 26 | N/A |
| 3/31/2024 | 139 | 6 | 19 | 29 | N/A |
| 12/31/2023 | 136 | 6 | 19 | 32 | N/A |
| 9/30/2023 | 126 | 9 | 7 | 24 | N/A |
| 6/30/2023 | 115 | 13 | -5 | 16 | N/A |
| 3/31/2023 | 106 | 10 | -9 | 10 | N/A |
| 12/31/2022 | 96 | 8 | -12 | 4 | N/A |
| 9/30/2022 | 91 | 6 | -8 | 4 | N/A |
| 6/30/2022 | 86 | 5 | -4 | 3 | N/A |
| 3/31/2022 | 85 | 7 | 5 | 12 | N/A |
| 12/31/2021 | 85 | 9 | 15 | 21 | N/A |
| 9/30/2021 | 85 | 7 | 16 | 22 | N/A |
| 6/30/2021 | 86 | 6 | 17 | 22 | N/A |
| 3/31/2021 | 89 | 7 | 9 | 14 | N/A |
| 12/31/2020 | 91 | 7 | 0 | 7 | N/A |
| 9/30/2020 | 93 | 10 | 1 | 13 | N/A |
| 6/30/2020 | 95 | 12 | 2 | 18 | N/A |
| 3/31/2020 | 101 | 15 | -1 | 16 | N/A |
| 12/31/2019 | 107 | 18 | -3 | 15 | N/A |
| 9/30/2019 | 107 | 20 | -7 | 11 | N/A |
| 6/30/2019 | 107 | 22 | -10 | 8 | N/A |
| 3/31/2019 | 97 | 20 | -7 | 11 | N/A |
| 12/31/2018 | 87 | 18 | -4 | 13 | N/A |
| 9/30/2018 | 80 | 16 | -5 | 12 | N/A |
| 6/30/2018 | 73 | 13 | -5 | 11 | N/A |
| 3/31/2018 | 72 | 13 | N/A | 14 | N/A |
| 12/31/2017 | 70 | 13 | N/A | 17 | N/A |
| 9/30/2017 | 69 | 12 | N/A | 19 | N/A |
| 6/30/2017 | 68 | 11 | N/A | 20 | N/A |
| 3/31/2017 | 66 | 11 | N/A | 20 | N/A |
| 12/31/2016 | 65 | 11 | N/A | 20 | N/A |
| 9/30/2016 | 63 | 13 | N/A | 19 | N/A |
| 6/30/2016 | 61 | 15 | N/A | 18 | N/A |
| 3/31/2016 | 60 | 14 | N/A | 15 | N/A |
| 12/31/2015 | 59 | 13 | N/A | 12 | N/A |
| 9/30/2015 | 60 | 12 | N/A | 16 | N/A |
| 6/30/2015 | 60 | 11 | N/A | 19 | N/A |
| 3/31/2015 | 59 | 12 | N/A | 20 | N/A |
| 12/31/2014 | 58 | 12 | N/A | 21 | N/A |
| 12/31/2013 | 47 | 10 | N/A | 10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: UMED's forecast earnings growth (60.7% per year) is above the savings rate (14.7%).
Earnings vs Market: UMED's earnings (60.7% per year) are forecast to grow faster than the TN market (2.9% per year).
High Growth Earnings: UMED's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: UMED's revenue (6.3% per year) is forecast to grow faster than the TN market (5.3% per year).
High Growth Revenue: UMED's revenue (6.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: UMED's Return on Equity is forecast to be low in 3 years time (19.6%).